Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2015, Article ID 707254, 7 pages
http://dx.doi.org/10.1155/2015/707254
Research Article

Serum Cytokine of IL-10 and IL-12 in Chronic Liver Disease: The Immune and Inflammatory Response

1Gastroenterology Laboratories, Gastroenterology Surgical Center, Mansoura University, Mansoura 35516, Egypt
2Molecular Biology Department, Genetic Engineering and Biotechnology Research Institute, Sadat University, Sadat City, Egypt
3Biochemistry Department, Faculty of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia
4Pathology Department, Faculty of Medicine, Mansoura University, Mansoura 35516, Egypt

Received 5 October 2015; Revised 12 November 2015; Accepted 23 November 2015

Academic Editor: Leigh A. Madden

Copyright © 2015 Hoda Mohamed El-Emshaty et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. S. Youssef, A. M. Abd El-Aal, A. Saad, M. H. Omran, T. El Zanaty, and S. M. Seif, “Impact of IL12B gene rs 3212227 polymorphism on fibrosis, liver inflammation, and response to treatment in genotype 4 Egyptian hepatitis c patients,” Disease Markers, vol. 35, no. 5, pp. 431–437, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. M. H. Omran, N. E. Ibrahim, S. S. Youssef et al., “Relation of interleukin-1β gene to treatment response in chronic patients infected with HCV genotype 4,” Journal of Infection in Developing Countries, vol. 7, no. 11, pp. 851–858, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. E. Billerbeck, T. Böttler, and R. Thimme, “Regulatory T cells in viral hepatitis,” World Journal of Gastroenterology, vol. 13, no. 36, pp. 4858–4864, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Hiroishi, T. Ito, and M. Imawari, “Immune responses in hepatitis C virus infection and mechanisms of hepatitis C virus persistence,” Journal of Gastroenterology and Hepatology, vol. 23, no. 10, pp. 1473–1482, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Guobužaitė, S. Chokshi, L. Balĉiuniene et al., “Viral clearance or persistence after acute hepatitis C infection: interim results from a prospective study,” Medicina, vol. 44, no. 7, pp. 510–520, 2008. View at Google Scholar · View at Scopus
  6. L. Wan, Y.-J. Kung, Y.-J. Lin et al., “Th1 and Th2 cytokines are elevated in HCV-infected SVR(-) patients treated with interferon-α,” Biochemical and Biophysical Research Communications, vol. 379, no. 4, pp. 855–860, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. A. K. Abbas and A. H. Lichtman, “Cytokines and effector mechanisms of cell-mediated immunity,” in Cellular and Molecular Immunology, pp. 243–317, Saunders, Philadelphia, Pa, USA, 5th edition, 2003. View at Google Scholar
  8. S.-L. Tsai, Y.-F. Liaw, M.-H. Chen, C.-Y. Huang, and G. C. Kuo, “Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity,” Hepatology, vol. 25, no. 2, pp. 449–458, 1997. View at Publisher · View at Google Scholar · View at Scopus
  9. W. E. Naugler and M. Karin, “The wolf in sheep's clothing: the role of interleukin-6 in immunity. Inflammation and cancer,” Trends in Molecular Medicine, vol. 14, no. 3, pp. 109–119, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Del Vecchio, E. Bajetta, S. Canova et al., “Interleukin-12: biological properties and clinical application,” Clinical Cancer Research, vol. 13, no. 16, pp. 4677–4685, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. W. T. Watford, M. Moriguchi, A. Morinobu, and J. J. O'Shea, “The biology of IL-12: coordinating innate and adaptive immune responses,” Cytokine and Growth Factor Reviews, vol. 14, no. 5, pp. 361–368, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Costantini, F. Capone, E. Guerriero, P. Maio, G. Colonna, and G. Castello, “Serum cytokine levels as putative prognostic markers in the progression of chronic HCV hepatitis to cirrhosis,” European Cytokine Network, vol. 21, no. 4, pp. 251–256, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. F. Capone, S. Costantini, E. Guerriero et al., “Serum cytokine levels in patients with hepatocellular carcinoma,” European Cytokine Network, vol. 21, no. 2, pp. 99–104, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Kakumu, A. Okumura, T. Ishikawa, K. Iwata, M. Yano, and K. Yoshioka, “Production of interleukins 10 and 12 by peripheral blood mononuclear cells (PBMC) in chronic hepatitis C virus (HCV) infection,” Clinical and Experimental Immunology, vol. 108, no. 1, pp. 138–143, 1997. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Sarih, N. Bouchrit, and A. Benslimane, “Different cytokine profiles of peripheral blood mononuclear cells from patients with persistent and self-limited hepatitis C virus infection,” Immunology Letters, vol. 74, no. 2, pp. 117–120, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. E. Gigi, M. Raptopoulou-Gigi, A. Kalogeridis et al., “Cytokine mRNA expression in hepatitis C virus infection: TH1 predominance in patients with chronic hepatitis C and TH1–TH2 cytokine profile in subjects with self-limited disease,” Journal of Viral Hepatitis, vol. 15, no. 2, pp. 145–154, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Taylor, J. Verhagen, K. Blaser, M. Akdis, and C. A. Akdis, “Mechanisms of immune suppression by interleukin-10 and transforming growth factor-β: the role of T regulatory cells,” Immunology, vol. 117, no. 4, pp. 433–442, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Yamashiki, A. Nishimura, and H. Suzuki, “Prognosis of chronic hepatitis C patients correlates with circulating monocyte/macrophage function,” Clinical Science, vol. 93, no. 4, p. 381, 1997. View at Publisher · View at Google Scholar · View at Scopus
  19. M. S. Othman, A. M. Aref, A. A. Mohamed, and W. A. Ibrahim, “Serum levels of interleukin-6 and interleukin-10 as biomarkers for Hepatocellular carcinoma in Egyptian patients,” ISRN Hepatology, vol. 2013, Article ID 412317, 9 pages, 2013. View at Publisher · View at Google Scholar
  20. E. Hattori, K. Okumoto, T. Adachi et al., “Possible contribution of circulating interleukin-10 (IL-10) to anti-tumor immunity and prognosis in patients with unresectable hepatocellular carcinoma,” Hepatology Research, vol. 27, no. 4, pp. 308–313, 2003. View at Google Scholar · View at Scopus
  21. D. Y. Kim, J. W. Kim, R. Kuromatsu, S. H. Ahn, T. Torimura, and M. Sherman, “Controversies in surveillance and early diagnosis of hepatocellular carcinoma,” Oncology, vol. 81, no. 1, pp. 56–60, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. A.-R. N. Zekri, M. S. El-din Ashour, A. Hassan, H. M. A. El-Din, A. M. R. El-Shehaby, and M. A. Abu-Shady, “Cytokine profile in Egyptian hepatitis C virus genotype-4 in relation to liver disease progression,” World Journal of Gastroenterology, vol. 11, no. 42, pp. 6624–6630, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. M. E. El-Houseini, M. S. Mohammed, W. M. Elshemey, T. D. Hussein, O. S. Desouky, and A. A. Elsayed, “Enhanced detection of hepatocellular carcinoma,” Cancer Control, vol. 12, no. 4, pp. 248–253, 2005. View at Google Scholar · View at Scopus
  24. C.-Y. Hsia, T.-I. Huo, S.-Y. Chiang et al., “Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma,” European Journal of Surgical Oncology, vol. 33, no. 2, pp. 208–212, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. J.-F. Wu, T.-C. Wu, C.-H. Chen et al., “Serum levels of interleukins-10 and interleukin-12 predict early, spontaneous hepatitis B virus e antigen seroconversion,” Gastroenterology, vol. 138, pp. 165–172, 2010. View at Google Scholar
  26. G. Schuler and R. M. Steinman, “Dendritic cells as adjuvants for immune-mediated resistance to tumors,” Journal of Experimental Medicine, vol. 186, no. 8, pp. 1183–1187, 1997. View at Publisher · View at Google Scholar · View at Scopus
  27. A.-R. N. Zekri, H. M. A. El-Din, A. A. Bahnassy et al., “Serum levels of soluble Fas, soluble tumor necrosis factor-receptor II, interleukin-2 receptor and interleukin-8 as early predictors of hepatocellular carcinoma in Egyptian patients with hepatitis C virus genotype-4,” Comparative Hepatology, vol. 9, article 1, 12 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. R. G. Gieling, K. Wallace, and Y.-P. Han, “Interleukin-1 participates in the progression from liver injury to fibrosis,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 296, no. 6, pp. G1324–G1331, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Tokusashi, K. Asai, S. Tamakawa et al., “Expression of NGF in hepatocellular carcinoma cells with its receptors in non-tumor cell components,” International Journal of Cancer, vol. 114, no. 1, pp. 39–45, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. G. Rasi, A. Serafino, L. Bellis et al., “Nerve growth factor involvement in liver cirrhosis and Hepatocellular carcinoma,” World Journal of Gastroenterology, vol. 13, no. 37, pp. 4986–4995, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. G. Liu, K. Tang, Q. Li, G. Yuan, W. Cao, and W. Lu, “Changes of IL-1, TNF-α, IL-12 and IL-10 levels with chronic liver failure,” Surgical Science, vol. 2, no. 2, pp. 69–72, 2011. View at Publisher · View at Google Scholar